Roberta Gualtierotti: Modern Approaches to Diagnosis and Treatment of Hemophilia A and B
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in JTH:
“From factor and non-factor replacement to gene therapy, hemophilia management is evolving rapidly, while hemophilic arthropathy remains a major unmet need.
Proud to share our educational review on the diagnosis and management of Hemophilia A and B, covering genetics, musculoskeletal complications, innovative therapies, cardiovascular comorbidities, and multidisciplinary care.
Educational Review in Press by the International Society on Thrombosis and Haemostasis (ISTH) SSC Subcommittee on FVIII and FIX.”
Title: Diagnosis and management of hemophilia A and B
Authors: Ming Y Lim, Jesús Ardila, Giancarlo Castaman, Yesim Dargaud, Karin Fijnvandraat, Roberta Gualtierotti, Cedric Hermans, Susan Shapiro
Other posts featuring Roberta Gualtierotti on Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy